|
HSD17B12 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.432510E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.201680E-04 |
| Normal-vs-Stage2 |
2.381500E-03 |
| Normal-vs-Stage3 |
7.56430000000696E-05 |
| Normal-vs-Stage4 |
1.06440000036123E-07 |
| Stage1-vs-Stage2 |
6.639400E-01 |
| Stage1-vs-Stage3 |
3.126200E-01 |
| Stage1-vs-Stage4 |
1.816710E-04 |
| Stage2-vs-Stage3 |
7.736800E-01 |
| Stage2-vs-Stage4 |
1.844160E-02 |
| Stage3-vs-Stage4 |
1.916190E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.12800000000324E-05 |
| Normal-vs-AfricanAmerican |
6.793700E-02 |
| Normal-vs-Asian |
2.977600E-03 |
| Caucasian-vs-AfricanAmerican |
2.925200E-01 |
| Caucasian-vs-Asian |
3.934600E-01 |
| AfricanAmerican-vs-Asian |
7.428000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.381200E-04 |
| Normal-vs-Female |
1.96730000001644E-06 |
| Male-vs-Female |
4.476000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.215480E-03 |
| Normal-vs-Age(41-60Yrs) |
3.07710000002626E-06 |
| Normal-vs-Age(61-80Yrs) |
7.72780000000139E-05 |
| Normal-vs-Age(81-100Yrs) |
9.246300E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.669800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.509570E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.624300E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.710600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.359800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.663900E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.246100E-02 |
| Classical-VS-Follicular |
2.939600E-01 |
| Classical-VS-Other |
6.215000E-01 |
| Classical-VS-Normal |
3.795700E-04 |
| Tall-VS-Follicular |
1.323640E-02 |
| Tall-VS-Other |
6.389600E-01 |
| Tall-VS-Normal |
1.71093999999927E-05 |
| Follicular-VS-Other |
4.441600E-01 |
| Follicular-VS-Normal |
7.675100E-03 |
| Other-VS-Normal |
6.635100E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.65510000000358E-05 |
| Normal-vs-N1 |
1.63737999999691E-05 |
| N0-vs-N1 |
7.763900E-02 |
|
|
